Loading...
Header Logo
Keywords
Last Name
Institution

Elizabeth C Bullen

TitleAsst,Research III
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentCell Biology
Phone405/271-2377
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sherry DM, Parks EE, Bullen EC, Updike DL, Howard EW. A simple method for using silicone elastomer masks for quantitative analysis of cell migration without cellular damage or substrate disruption. Cell Adh Migr. 2013 Nov-Dec; 7(6):469-75. PMID: 24430202.
      View in: PubMed
    2. Howard EW, Been LF, Lerner M, Brackett D, Lightfoot S, Bullen EC, Sanghera DK. Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2. BMC Genet. 2013 Apr 23; 14:28. PMID: 23617586.
      View in: PubMed
    3. Howard EW, Crider BJ, Updike DL, Bullen EC, Parks EE, Haaksma CJ, Sherry DM, Tomasek JJ. MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype. Exp Cell Res. 2012 Aug 01; 318(13):1542-53. PMID: 22449415.
      View in: PubMed
    4. Risinger GM, Updike DL, Bullen EC, Tomasek JJ, Howard EW. TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol. 2010 Jan; 298(1):C191-201. PMID: 19846754.
      View in: PubMed
    5. Vogel JS, Bullen EC, Teygong CL, Howard EW. Identification of the RLBP1 gene promoter. Invest Ophthalmol Vis Sci. 2007 Aug; 48(8):3872-7. PMID: 17652763.
      View in: PubMed
    6. Risinger GM, Hunt TS, Updike DL, Bullen EC, Howard EW. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem. 2006 Sep 08; 281(36):25915-25. PMID: 16854986.
      View in: PubMed
    7. Zang XP, Bullen EC, Manjeshwar S, Jupe ER, Howard EW, Pento JT. Enhanced motility of KGF-transfected breast cancer cells. Anticancer Res. 2006 Mar-Apr; 26(2A):961-6. PMID: 16619493.
      View in: PubMed
    8. Phelps ED, Updike DL, Bullen EC, Grammas P, Howard EW. Transcriptional and posttranscriptional regulation of angiopoietin-2 expression mediated by IGF and PDGF in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2006 Feb; 290(2):C352-61. PMID: 16176970.
      View in: PubMed
    9. Bottles KD, Bullen EC, Updike DL, Vu TK, Phelps E, Grammas P, Howard EW. Gelatinase A expression in endothelial cells is regulated by at least two cis-acting promoter elements. Biochim Biophys Acta. 1999 Aug 05; 1428(2-3):147-60. PMID: 10434032.
      View in: PubMed
    10. Bass KE, Li H, Hawkes SP, Howard E, Bullen E, Vu TK, McMaster M, Janatpour M, Fisher SJ. Tissue inhibitor of metalloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. Dev Genet. 1997; 21(1):61-7. PMID: 9291581.
      View in: PubMed
    11. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol. 1995 Feb; 104(2):236-40. PMID: 7829879.
      View in: PubMed
    12. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem. 1991 Jul 15; 266(20):13070-5. PMID: 1649175.
      View in: PubMed
    13. Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem. 1991 Jul 15; 266(20):13064-9. PMID: 2071592.
      View in: PubMed
    Bullen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Same Department Expand Description